Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.14 trillion and total revenue of $105.3 billion.
Market Cap
1.14T
Revenue
105.3B
Profits
-41.5B
PE Ratio
n/a
Profit Margin
-39.41%
Dividend Yield
0.05%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 117.00B | 4.31% | 2,289,568 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.88B | 2.12% | 787,138 | 14.25B |
| 3 | ARGX | argenx SE | 49.82B | 0.83% | 392,387 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 48.28B | 2.79% | 1,522,053 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 37.81B | 2.20% | 315,798 | 4.97B |
| 6 | INSM | Insmed Incorporated | 33.34B | -4.40% | 2,940,213 | 447.02M |
| 7 | BNTX | BioNTech SE | 29.61B | 11.78% | 2,111,440 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.93B | 1.61% | 5,321,937 | 2.35B |
| 9 | RVMD | Revolution Medicines, Inc. | 22.72B | 1.13% | 3,876,205 | - |
| 10 | INCY | Incyte Corporation | 20.55B | 2.00% | 1,569,200 | 4.81B |
| 11 | GMAB | Genmab A/S | 20.15B | 5.17% | 2,282,693 | 3.85B |
| 12 | MRNA | Moderna, Inc. | 19.46B | 15.84% | 22,610,466 | 2.23B |
| 13 | ROIV | Roivant Sciences Ltd. | 15.98B | - | 4,916,716 | 20.33M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 15.06B | 1.24% | 2,211,979 | 353.78M |
| 15 | ASND | Ascendis Pharma A/S | 13.30B | 0.50% | 654,502 | 758.59M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.99B | 4.92% | 3,850,958 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.87B | 2.46% | 3,297,896 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 12.06B | 2.35% | 2,007,872 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.29B | -1.58% | 313,258 | 740.64M |
| 20 | TECH | Bio-Techne Corporation | 11.12B | 2.59% | 2,698,929 | 1.22B |
| 21 | RNA | Avidity Biosciences, Inc. | 10.95B | 0.25% | 1,797,206 | 20.87M |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.91B | 0.82% | 2,066,337 | 3.09B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.28B | 0.76% | 641,502 | 4.16B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 9.53B | 2.49% | 1,389,138 | 561.26M |
| 25 | ABVX | ABIVAX Société Anonyme | 9.34B | 0.98% | 798,215 | 6.23M |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.29B | 3.55% | 1,548,103 | 829.45M |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 8.67B | -3.54% | 616,723 | 7.46M |
| 28 | NUVL | Nuvalent, Inc. | 8.47B | 2.94% | 437,532 | - |
| 29 | HALO | Halozyme Therapeutics, Inc. | 8.43B | 1.82% | 1,087,285 | 1.24B |
| 30 | KRYS | Krystal Biotech, Inc. | 8.29B | 4.07% | 246,878 | 373.16M |
| 31 | CYTK | Cytokinetics, Incorporated | 7.71B | -1.16% | 1,951,442 | 87.21M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.19B | -3.01% | 1,970,156 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.08B | 3.34% | 496,054 | 174.33M |
| 34 | IBRX | ImmunityBio, Inc. | 6.82B | 6.79% | 96,029,548 | 82.56M |
| 35 | PCVX | Vaxcyte, Inc. | 6.57B | 5.64% | 1,283,682 | - |
| 36 | GPCR | Structure Therapeutics Inc. | 6.48B | 3.04% | 2,040,218 | - |
| 37 | COGT | Cogent Biosciences, Inc. | 6.07B | - | 3,171,549 | - |
| 38 | PTCT | PTC Therapeutics, Inc. | 6.07B | 3.41% | 1,199,522 | 1.78B |
| 39 | BLTE | Belite Bio, Inc | 5.97B | -0.51% | 100,900 | - |
| 40 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.68B | -0.50% | 979,178 | 1.54M |
| 41 | KYMR | Kymera Therapeutics, Inc. | 5.66B | 3.82% | 612,137 | 43.74M |
| 42 | APGE | Apogee Therapeutics, Inc. | 5.53B | -0.16% | 729,349 | - |
| 43 | IMVT | Immunovant, Inc. | 5.27B | -0.46% | 1,309,547 | - |
| 44 | PTGX | Protagonist Therapeutics, Inc. | 5.24B | 0.56% | 1,086,068 | 209.22M |
| 45 | CRSP | CRISPR Therapeutics AG | 5.22B | 4.03% | 1,570,869 | 38.34M |
| 46 | CELC | Celcuity Inc. | 4.96B | 1.68% | 670,948 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 4.82B | 1.50% | 1,962,553 | 471.79M |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.70B | 2.93% | 1,173,038 | - |
| 49 | TGTX | TG Therapeutics, Inc. | 4.62B | 2.04% | 1,589,176 | 531.90M |
| 50 | CGON | CG Oncology, Inc. | 4.61B | 4.46% | 2,888,323 | 2.17M |
| 51 | ACAD | ACADIA Pharmaceuticals Inc. | 4.53B | 1.79% | 1,373,782 | 1.05B |
| 52 | FOLD | Amicus Therapeutics, Inc. | 4.44B | 0.28% | 4,321,473 | 598.70M |
| 53 | ADMA | ADMA Biologics, Inc. | 4.13B | -1.31% | 1,850,475 | 488.56M |
| 54 | TERN | Terns Pharmaceuticals, Inc. | 3.99B | 0.22% | 1,531,482 | - |
| 55 | ACLX | Arcellx, Inc. | 3.98B | -4.57% | 1,242,200 | 35.90M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 3.93B | 1.50% | 196,714 | 251.23M |
| 57 | NAMS | NewAmsterdam Pharma Company N.V. | 3.85B | 4.72% | 927,067 | 35.24M |
| 58 | LEGN | Legend Biotech Corporation | 3.83B | -11.36% | 8,099,701 | 909.05M |
| 59 | CORT | Corcept Therapeutics Incorporated | 3.82B | 2.89% | 1,436,296 | 741.17M |
| 60 | VKTX | Viking Therapeutics, Inc. | 3.77B | -0.42% | 2,437,410 | - |
| 61 | LQDA | Liquidia Corporation | 3.48B | 1.59% | 1,738,165 | 69.22M |
| 62 | CNTA | Centessa Pharmaceuticals plc | 3.39B | 1.35% | 6,463,841 | 15.00M |
| 63 | ALMS | Alumis Inc. | 3.33B | 2.38% | 1,846,960 | 22.12M |
| 64 | ARQT | Arcutis Biotherapeutics, Inc. | 3.27B | 3.21% | 1,741,543 | 317.93M |
| 65 | VERA | Vera Therapeutics, Inc. | 3.25B | 2.10% | 1,284,315 | - |
| 66 | XENE | Xenon Pharmaceuticals Inc. | 3.17B | -1.18% | 1,434,086 | 7.50M |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.16B | 0.73% | 755,025 | 214.83M |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.10B | 1.78% | 1,568,641 | - |
| 69 | VRDN | Viridian Therapeutics, Inc. | 3.08B | -1.07% | 1,035,238 | 70.79M |
| 70 | BEAM | Beam Therapeutics Inc. | 3.07B | 0.48% | 2,214,875 | 55.70M |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 3.02B | 0.45% | 530,083 | 366.10M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.97B | 3.21% | 929,782 | 578.20M |
| 73 | DNLI | Denali Therapeutics Inc. | 2.90B | 6.10% | 1,845,917 | - |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.88B | 5.55% | 1,400,591 | - |
| 75 | ERAS | Erasca, Inc. | 2.85B | 2.45% | 9,087,904 | - |
| 76 | RCUS | Arcus Biosciences, Inc. | 2.84B | 4.56% | 806,272 | 240.00M |
| 77 | IRON | Disc Medicine, Inc. | 2.83B | 1.20% | 440,485 | - |
| 78 | IMNM | Immunome, Inc. | 2.74B | 4.15% | 2,008,721 | 9.68M |
| 79 | ADPT | Adaptive Biotechnologies Corporation | 2.68B | -1.68% | 1,668,072 | 252.75M |
| 80 | APLS | Apellis Pharmaceuticals, Inc. | 2.65B | 2.34% | 4,691,502 | 1.02B |
| 81 | SYRE | Spyre Therapeutics, Inc. | 2.64B | 0.77% | 512,279 | - |
| 82 | WVE | Wave Life Sciences Ltd. | 2.55B | 0.87% | 2,438,421 | 109.23M |
| 83 | TVTX | Travere Therapeutics, Inc. | 2.53B | 1.11% | 1,910,998 | 435.83M |
| 84 | MLYS | Mineralys Therapeutics, Inc. | 2.48B | -1.94% | 938,329 | - |
| 85 | OCUL | Ocular Therapeutix, Inc. | 2.43B | -0.26% | 4,153,514 | 55.78M |
| 86 | TLX | Telix Pharmaceuticals Limited | 2.43B | -5.43% | 271,889 | 664.23M |
| 87 | RXRX | Recursion Pharmaceuticals, Inc. | 2.40B | 4.77% | 26,949,133 | 43.69M |
| 88 | AAPG | Ascentage Pharma Group International | 2.36B | -0.13% | 8,681 | 54.52M |
| 89 | SLNO | Soleno Therapeutics, Inc. | 2.34B | -0.39% | 902,099 | 98.68M |
| 90 | SRPT | Sarepta Therapeutics, Inc. | 2.24B | 1.57% | 2,281,437 | 2.41B |
| 91 | GLPG | Galapagos NV | 2.20B | 0.01% | 162,237 | 336.64M |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.19B | 0.53% | 3,048,846 | 630.60M |
| 93 | MESO | Mesoblast Limited | 2.18B | 3.15% | 284,732 | 17.20M |
| 94 | HRMY | Harmony Biosciences Holdings, Inc. | 2.11B | 2.17% | 496,596 | 825.94M |
| 95 | NUVB | Nuvation Bio Inc. | 2.11B | 2.33% | 6,274,165 | 26.75M |
| 96 | MAZE | Maze Therapeutics, Inc. | 2.10B | -1.44% | 427,826 | 2.50M |
| 97 | ZLAB | Zai Lab Limited | 2.10B | -0.37% | 733,425 | 441.63M |
| 98 | OLMA | Olema Pharmaceuticals, Inc. | 2.07B | -1.61% | 723,691 | - |
| 99 | DNTH | Dianthus Therapeutics, Inc. | 2.06B | 3.07% | 743,115 | 3.08M |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.95B | -0.07% | 776,920 | 265.81M |
| 101 | ARDX | Ardelyx, Inc. | 1.94B | 2.96% | 8,189,857 | 398.23M |
| 102 | NRIX | Nurix Therapeutics, Inc. | 1.93B | 4.28% | 1,274,859 | 83.69M |
| 103 | GLUE | Monte Rosa Therapeutics, Inc. | 1.92B | -0.86% | 806,514 | 181.54M |
| 104 | VCEL | Vericel Corporation | 1.91B | 3.94% | 381,959 | 258.72M |
| 105 | MBX | MBX Biosciences, Inc. | 1.85B | -4.75% | 751,469 | - |
| 106 | SION | Sionna Therapeutics, Inc. | 1.82B | 1.95% | 192,344 | - |
| 107 | ZYME | Zymeworks Inc. | 1.79B | 1.10% | 640,210 | 134.48M |
| 108 | PHVS | Pharvaris N.V. | 1.79B | 4.92% | 154,714 | - |
| 109 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 1.43% | 1,113,265 | 111.30M |
| 110 | IMCR | Immunocore Holdings plc | 1.78B | 5.76% | 1,043,842 | 379.59M |
| 111 | MNKD | MannKind Corporation | 1.75B | 4.01% | 4,156,407 | 313.79M |
| 112 | CLDX | Celldex Therapeutics, Inc. | 1.74B | 4.10% | 366,057 | 2.60M |
| 113 | BHVN | Biohaven Ltd. | 1.71B | 1.50% | 3,478,779 | - |
| 114 | UPB | Upstream Bio, Inc. | 1.71B | 1.90% | 468,365 | 2.80M |
| 115 | DFTX | Definium Therapeutics, Inc. | 1.69B | 2.21% | 2,774,344 | - |
| 116 | STOK | Stoke Therapeutics, Inc. | 1.68B | 2.72% | 567,371 | 205.63M |
| 117 | TNGX | Tango Therapeutics, Inc. | 1.68B | - | 4,608,547 | 66.50M |
| 118 | RAPT | RAPT Therapeutics, Inc. | 1.67B | 0.07% | 1,891,630 | - |
| 119 | ORKA | Oruka Therapeutics, Inc. | 1.67B | 3.70% | 744,287 | - |
| 120 | KOD | Kodiak Sciences Inc. | 1.66B | 0.26% | 534,383 | - |
| 121 | CRVS | Corvus Pharmaceuticals, Inc. | 1.65B | 3.46% | 15,175,589 | - |
| 122 | NTLA | Intellia Therapeutics, Inc. | 1.63B | 9.35% | 9,239,250 | 57.53M |
| 123 | ELVN | Enliven Therapeutics, Inc. | 1.61B | 0.57% | 1,073,423 | - |
| 124 | NVAX | Novavax, Inc. | 1.61B | 20.73% | 16,566,476 | 1.06B |
| 125 | AGIO | Agios Pharmaceuticals, Inc. | 1.58B | 1.84% | 1,133,090 | 44.79M |
| 126 | PGEN | Precigen, Inc. | 1.58B | 1.59% | 2,389,907 | 6.31M |
| 127 | FTRE | Fortrea Holdings Inc. | 1.57B | 7.52% | 887,849 | 2.76B |
| 128 | TYRA | Tyra Biosciences, Inc. | 1.57B | -0.27% | 550,524 | - |
| 129 | OCS | Oculis Holding AG | 1.51B | 0.15% | 384,051 | 992.00K |
| 130 | SVRA | Savara Inc. | 1.49B | 3.69% | 1,353,923 | - |
| 131 | INVA | Innoviva, Inc. | 1.47B | 0.26% | 461,014 | 388.52M |
| 132 | ATAI | AtaiBeckley Inc. | 1.42B | 1.30% | 3,407,502 | 3.02M |
| 133 | QURE | uniQure N.V. | 1.35B | -2.95% | 1,433,907 | 15.75M |
| 134 | IMTX | Immatics N.V. | 1.34B | 1.11% | 254,586 | 99.45M |
| 135 | TRVI | Trevi Therapeutics, Inc. | 1.32B | -1.15% | 1,063,206 | - |
| 136 | DBVT | DBV Technologies S.A. | 1.31B | 3.73% | 571,300 | 5.50M |
| 137 | TSHA | Taysha Gene Therapies, Inc. | 1.31B | 3.02% | 1,991,682 | 6.31M |
| 138 | RLAY | Relay Therapeutics, Inc. | 1.31B | 1.75% | 2,805,456 | 8.36M |
| 139 | ANAB | AnaptysBio, Inc. | 1.29B | 1.02% | 215,861 | 169.47M |
| 140 | EYPT | EyePoint, Inc. | 1.29B | -0.06% | 961,120 | 42.34M |
| 141 | ABCL | AbCellera Biologics Inc. | 1.28B | 2.88% | 3,899,663 | 35.33M |
| 142 | SANA | Sana Biotechnology, Inc. | 1.27B | 3.93% | 2,276,905 | - |
| 143 | XERS | Xeris Biopharma Holdings, Inc. | 1.26B | 0.13% | 1,461,900 | 266.14M |
| 144 | RAPP | Rapport Therapeutics, Inc. | 1.26B | 1.66% | 369,872 | - |
| 145 | CAPR | Capricor Therapeutics, Inc. | 1.26B | 0.45% | 1,475,663 | 11.13M |
| 146 | DAWN | Day One Biopharmaceuticals, Inc. | 1.24B | -0.33% | 4,762,702 | 133.67M |
| 147 | IVA | Inventiva S.A. | 1.23B | 2.33% | 1,562,541 | 19.93M |
| 148 | PHAR | Pharming Group N.V. | 1.22B | - | 19,149 | 362.27M |
| 149 | ORIC | ORIC Pharmaceuticals, Inc. | 1.19B | 5.42% | 1,353,876 | - |
| 150 | MLTX | MoonLake Immunotherapeutics | 1.19B | 2.33% | 2,462,852 | - |
| 151 | SEPN | Septerna, Inc. | 1.18B | -2.42% | 178,523 | 22.05M |
| 152 | PVLA | Palvella Therapeutics, Inc. | 1.11B | -4.17% | 278,290 | - |
| 153 | INBX | Inhibrx Biosciences, Inc. | 1.09B | 3.02% | 146,637 | 1.40M |
| 154 | AKTS | Aktis Oncology, Inc. | 1.07B | 8.68% | 310,685 | 5.56M |
| 155 | PHAT | Phathom Pharmaceuticals, Inc. | 1.07B | -3.82% | 1,604,781 | 147.19M |
| 156 | ZBIO | Zenas BioPharma, Inc. | 1.05B | -6.18% | 831,500 | 15.00M |
| 157 | CMPX | Compass Therapeutics, Inc. | 1.05B | 3.33% | 1,921,313 | 850.00K |
| 158 | TBPH | Theravance Biopharma, Inc. | 1.03B | -0.24% | 255,491 | 80.33M |
| 159 | SPRY | ARS Pharmaceuticals, Inc. | 1.03B | -0.10% | 1,584,177 | 142.77M |
| 160 | ANNX | Annexon, Inc. | 1.02B | 11.20% | 2,997,426 | - |
| 161 | GHRS | GH Research PLC | 1.02B | 3.94% | 294,026 | - |
| 162 | IOVA | Iovance Biotherapeutics, Inc. | 996.39M | 2.87% | 12,058,704 | 250.43M |
| 163 | VTYX | Ventyx Biosciences, Inc. | 995.17M | -0.07% | 3,163,554 | - |
| 164 | NBTX | Nanobiotix S.A. | 985.87M | -4.43% | 15,909 | 11.93M |
| 165 | MRVI | Maravai LifeSciences Holdings, Inc. | 979.36M | 2.13% | 956,191 | 192.44M |
| 166 | VIR | Vir Biotechnology, Inc. | 965.53M | 15.67% | 3,048,752 | 16.86M |
| 167 | AVBP | ArriVent BioPharma, Inc. | 944.52M | 2.79% | 478,852 | - |
| 168 | BCAX | Bicara Therapeutics Inc. | 929.65M | 1.50% | 620,451 | - |
| 169 | XNCR | Xencor, Inc. | 928.34M | 2.85% | 678,999 | 150.13M |
| 170 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 911.07M | -0.61% | 343,823 | - |
| 171 | URGN | UroGen Pharma Ltd. | 900.13M | -0.52% | 813,948 | 96.52M |
| 172 | CTMX | CytomX Therapeutics, Inc. | 896.31M | -1.49% | 2,371,432 | 113.63M |
| 173 | OMER | Omeros Corporation | 856.48M | -1.47% | 2,228,134 | - |
| 174 | VALN | Valneva SE | 855.92M | 1.54% | 6,994 | 211.09M |
| 175 | GERN | Geron Corporation | 855.40M | 3.08% | 7,593,125 | 183.40M |
| 176 | YDES | YD Bio Limited | 843.84M | 0.42% | 53,145 | 510.36K |
| 177 | ARVN | Arvinas, Inc. | 809.23M | 4.74% | 604,949 | 312.30M |
| 178 | KALV | KalVista Pharmaceuticals, Inc. | 804.19M | 3.92% | 751,822 | 1.43M |
| 179 | DRUG | Bright Minds Biosciences Inc. | 799.11M | 3.66% | 82,737 | - |
| 180 | JANX | Janux Therapeutics, Inc. | 798.16M | 0.91% | 1,500,734 | 10.00M |
| 181 | ABUS | Arbutus Biopharma Corporation | 796.22M | -1.55% | 1,290,316 | 14.61M |
| 182 | MDXG | MiMedx Group, Inc. | 789.38M | -1.11% | 809,544 | 393.44M |
| 183 | SLS | SELLAS Life Sciences Group, Inc. | 779.89M | 6.02% | 9,509,717 | - |
| 184 | RGNX | REGENXBIO Inc. | 760.36M | 6.52% | 889,325 | 161.32M |
| 185 | KURA | Kura Oncology, Inc. | 758.79M | 1.40% | 1,237,438 | 104.03M |
| 186 | GYRE | Gyre Therapeutics, Inc. | 754.39M | 4.67% | 179,108 | 107.27M |
| 187 | NKTR | Nektar Therapeutics | 751.01M | 1.90% | 805,879 | 62.60M |
| 188 | MPLT | MapLight Therapeutics, Inc. | 739.72M | -0.47% | 197,036 | - |
| 189 | NBY | NovaBay Pharmaceuticals, Inc. | 739.68M | -9.69% | 2,047,471 | 10.30M |
| 190 | JBIO | Jade Biosciences, Inc. | 733.31M | 4.52% | 357,312 | - |
| 191 | ATXS | Astria Therapeutics, Inc. | 713.56M | 0.48% | 940,030 | 706.00K |
| 192 | PRME | Prime Medicine, Inc. | 709.92M | 3.08% | 2,949,147 | 5.98M |
| 193 | VOR | Vor Biopharma Inc. | 700.06M | 2.73% | 951,931 | - |
| 194 | FULC | Fulcrum Therapeutics, Inc. | 687.41M | -1.70% | 968,016 | 80.00M |
| 195 | CGEM | Cullinan Therapeutics, Inc. | 685.28M | 6.72% | 613,962 | - |
| 196 | RIGL | Rigel Pharmaceuticals, Inc. | 683.22M | 3.58% | 289,746 | 282.08M |
| 197 | PROK | ProKidney Corp. | 646.79M | 0.47% | 1,242,349 | 744.00K |
| 198 | GOSS | Gossamer Bio, Inc. | 634.19M | 5.38% | 6,338,582 | 44.05M |
| 199 | TENX | Tenax Therapeutics, Inc. | 630.87M | -5.30% | 197,890 | - |
| 200 | ENGN | enGene Holdings Inc. | 625.64M | 2.64% | 648,597 | - |
| 201 | IVVD | Invivyd, Inc. | 623.19M | -1.34% | 2,751,296 | 50.04M |
| 202 | MGTX | MeiraGTx Holdings plc | 614.15M | 4.23% | 522,592 | 27.42M |
| 203 | LENZ | LENZ Therapeutics, Inc. | 609.53M | 0.52% | 1,330,902 | 17.50M |
| 204 | EVMN | Evommune, Inc. | 594.23M | 2.45% | 265,174 | 13.00M |
| 205 | KROS | Keros Therapeutics, Inc. | 579.46M | 3.20% | 254,557 | 246.72M |
| 206 | CRMD | CorMedix Inc. | 577.52M | 6.54% | 2,807,332 | 214.30M |
| 207 | REPL | Replimune Group, Inc. | 569.50M | 3.57% | 4,140,234 | - |
| 208 | LXRX | Lexicon Pharmaceuticals, Inc. | 566.90M | 19.08% | 10,478,588 | 70.86M |
| 209 | FBRX | Forte Biosciences, Inc. | 561.69M | 3.49% | 160,015 | - |
| 210 | DNA | Ginkgo Bioworks Holdings, Inc. | 555.86M | 8.31% | 776,695 | 180.61M |
| 211 | DRTS | Alpha Tau Medical Ltd. | 553.36M | 0.46% | 233,628 | - |
| 212 | LBRX | LB Pharmaceuticals Inc | 549.50M | 0.74% | 256,475 | - |
| 213 | ANRO | Alto Neuroscience, Inc. | 546.46M | 0.98% | 98,342 | - |
| 214 | DSGN | Design Therapeutics, Inc. | 544.00M | 1.06% | 165,128 | - |
| 215 | KYTX | Kyverna Therapeutics, Inc. | 541.59M | 5.10% | 1,297,431 | - |
| 216 | LXEO | Lexeo Therapeutics, Inc. | 527.70M | -0.41% | 1,458,419 | - |
| 217 | PRTA | Prothena Corporation plc | 521.07M | 4.65% | 591,425 | 11.79M |
| 218 | LYEL | Lyell Immunopharma, Inc. | 512.40M | 0.92% | 193,488 | 41.00K |
| 219 | ZVRA | Zevra Therapeutics, Inc. | 508.37M | 0.11% | 958,110 | 84.39M |
| 220 | ALT | Altimmune, Inc. | 504.30M | 9.22% | 3,908,139 | 20.00K |
| 221 | NAGE | Niagen Bioscience, Inc. | 496.55M | -0.16% | 566,696 | 124.71M |
| 222 | VSTM | Verastem, Inc. | 490.88M | -4.36% | 1,260,073 | 13.38M |
| 223 | SLDB | Solid Biosciences Inc. | 479.93M | 9.61% | 1,201,920 | - |
| 224 | ACRS | Aclaris Therapeutics, Inc. | 478.89M | -0.23% | 5,054,413 | 15.74M |
| 225 | BCYC | Bicycle Therapeutics plc | 478.64M | 3.45% | 141,215 | 28.34M |
| 226 | AVXL | Anavex Life Sciences Corp. | 473.54M | 5.37% | 1,425,517 | - |
| 227 | MNPR | Monopar Therapeutics Inc. | 470.39M | 0.10% | 386,560 | - |
| 228 | VNDA | Vanda Pharmaceuticals Inc. | 468.64M | 2.85% | 957,791 | 212.07M |
| 229 | OCGN | Ocugen, Inc. | 465.36M | -10.78% | 10,660,325 | 5.37M |
| 230 | EPRX | Eupraxia Pharmaceuticals Inc. | 458.46M | 0.11% | 262,524 | - |
| 231 | ABSI | Absci Corporation | 454.12M | 4.14% | 2,924,451 | 2.82M |
| 232 | CTNM | Contineum Therapeutics, Inc. | 445.66M | 2.95% | 119,654 | - |
| 233 | ADCT | ADC Therapeutics SA | 442.24M | 1.42% | 1,087,910 | 75.21M |
| 234 | FDMT | 4D Molecular Therapeutics, Inc. | 439.37M | 0.92% | 460,397 | 120.00K |
| 235 | NBP | NovaBridge Biosciences | 436.95M | -3.32% | 862,465 | - |
| 236 | PRTC | PureTech Health plc | 434.43M | -4.55% | 1,111 | 6.39M |
| 237 | DMAC | DiaMedica Therapeutics Inc. | 427.02M | 7.41% | 374,351 | - |
| 238 | ASMB | Assembly Biosciences, Inc. | 416.78M | -1.68% | 116,264 | 37.19M |
| 239 | ZURA | Zura Bio Limited | 410.95M | 26.15% | 4,561,743 | - |
| 240 | BNTC | Benitec Biopharma Inc. | 410.41M | 4.21% | 93,586 | - |
| 241 | VTVT | vTv Therapeutics Inc. | 410.11M | 4.35% | 5,819 | 17.00K |
| 242 | IMMP | Immutep Limited | 408.62M | 0.71% | 151,973 | 3.31M |
| 243 | TRDA | Entrada Therapeutics, Inc. | 405.24M | 6.40% | 214,697 | 61.52M |
| 244 | LCTX | Lineage Cell Therapeutics, Inc. | 402.26M | 0.61% | 647,543 | 10.82M |
| 245 | RCKT | Rocket Pharmaceuticals, Inc. | 399.34M | 1.37% | 2,130,771 | - |
| 246 | AUTL | Autolus Therapeutics plc | 391.23M | 3.52% | 1,426,312 | 51.13M |
| 247 | HELP | Cybin Inc. | 376.77M | -1.69% | 331,353 | - |
| 248 | PEPG | PepGen Inc. | 371.93M | -9.08% | 730,857 | - |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 362.80M | 0.64% | 253,619 | 65.32M |
| 250 | ALLO | Allogene Therapeutics, Inc. | 359.57M | 1.91% | 4,293,918 | 22.00K |
| 251 | FHTX | Foghorn Therapeutics Inc. | 356.18M | 9.16% | 229,899 | 24.52M |
| 252 | TECX | Tectonic Therapeutic, Inc. | 352.61M | -1.54% | 182,393 | - |
| 253 | AURA | Aura Biosciences, Inc. | 348.00M | 10.26% | 190,354 | - |
| 254 | PBYI | Puma Biotechnology, Inc. | 347.19M | 4.39% | 603,274 | 212.00M |
| 255 | CADL | Candel Therapeutics, Inc. | 345.86M | 6.42% | 715,555 | - |
| 256 | AARD | Aardvark Therapeutics, Inc. | 344.45M | 1.93% | 253,614 | - |
| 257 | XOMA | XOMA Royalty Corporation | 337.69M | 4.44% | 522,842 | 47.11M |
| 258 | ACIU | AC Immune SA | 336.41M | 2.41% | 268,212 | 5.48M |
| 259 | NMRA | Neumora Therapeutics, Inc. | 331.38M | 4.28% | 899,023 | - |
| 260 | XFOR | X4 Pharmaceuticals, Inc. | 327.89M | 2.18% | 192,993 | 33.98M |
| 261 | IMRX | Immuneering Corporation | 313.16M | 1.46% | 1,606,124 | - |
| 262 | TARA | Protara Therapeutics, Inc. | 309.20M | 3.04% | 1,635,953 | - |
| 263 | GLSI | Greenwich LifeSciences, Inc. | 308.96M | 4.74% | 505,165 | - |
| 264 | ALDX | Aldeyra Therapeutics, Inc. | 300.21M | 5.05% | 1,192,854 | - |
| 265 | CLLS | Cellectis S.A. | 293.11M | -0.96% | 36,639 | 82.55M |
| 266 | AVTX | Avalo Therapeutics, Inc. | 291.76M | 6.49% | 332,278 | 192.00K |
| 267 | OABI | OmniAb, Inc. | 289.35M | 5.79% | 507,607 | 21.09M |
| 268 | ACHV | Achieve Life Sciences, Inc. | 288.53M | -1.28% | 864,884 | - |
| 269 | ABEO | Abeona Therapeutics Inc. | 287.76M | - | 1,194,669 | 400.00K |
| 270 | LRMR | Larimar Therapeutics, Inc. | 284.16M | 3.75% | 571,300 | - |
| 271 | GUTS | Fractyl Health, Inc. | 283.74M | -3.14% | 3,858,164 | 3.00K |
| 272 | NGNE | Neurogene Inc. | 283.62M | 4.51% | 72,793 | 925.00K |
| 273 | STTK | Shattuck Labs, Inc. | 280.96M | 2.30% | 314,676 | 1.00M |
| 274 | RZLT | Rezolute, Inc. | 280.04M | 4.50% | 2,861,569 | - |
| 275 | RLMD | Relmada Therapeutics, Inc. | 279.40M | -3.30% | 369,596 | - |
| 276 | NAUT | Nautilus Biotechnology, Inc. | 275.35M | 6.34% | 200,542 | - |
| 277 | AVIR | Atea Pharmaceuticals, Inc. | 275.01M | 2.33% | 278,734 | - |
| 278 | SLN | Silence Therapeutics plc | 268.29M | 9.23% | 576,038 | 25.83M |
| 279 | CBIO | Crescent Biopharma, Inc. | 268.22M | -1.86% | 196,221 | - |
| 280 | HRTX | Heron Therapeutics, Inc. | 267.71M | 2.82% | 1,430,161 | 155.10M |
| 281 | FENC | Fennec Pharmaceuticals Inc. | 262.98M | 4.19% | 87,300 | 38.79M |
| 282 | PALI | Palisade Bio, Inc. | 260.76M | -7.41% | 5,955,751 | - |
| 283 | IMMX | Immix Biopharma, Inc. | 257.68M | 6.30% | 1,009,891 | - |
| 284 | MENS | Jyong Biotech Ltd. | 245.31M | -2.15% | 383,887 | - |
| 285 | IKT | Inhibikase Therapeutics, Inc. | 239.37M | 6.06% | 883,952 | 1.00 |
| 286 | CAMP | Camp4 Therapeutics Corporation | 233.47M | 1.35% | 92,499 | 3.80M |
| 287 | ENLV | Enlivex Therapeutics Ltd. | 232.87M | 0.10% | 616,050 | - |
| 288 | OBIO | Orchestra BioMed Holdings, Inc. | 230.94M | 1.24% | 104,588 | 2.82M |
| 289 | CABA | Cabaletta Bio, Inc. | 225.26M | 6.85% | 2,320,651 | - |
| 290 | TNXP | Tonix Pharmaceuticals Holding Corp. | 225.15M | 6.63% | 407,387 | 10.30M |
| 291 | NVCT | Nuvectis Pharma, Inc. | 219.78M | 5.92% | 57,891 | - |
| 292 | MDWD | MediWound Ltd. | 218.86M | 0.41% | 173,319 | 20.93M |
| 293 | ARMP | Armata Pharmaceuticals, Inc. | 217.71M | 1.18% | 30,836 | 5.05M |
| 294 | TLSA | Tiziana Life Sciences Ltd | 214.13M | 8.23% | 375,457 | - |
| 295 | OVID | Ovid Therapeutics Inc. | 213.50M | 7.89% | 1,547,541 | 6.61M |
| 296 | VYGR | Voyager Therapeutics, Inc. | 209.61M | 2.72% | 791,360 | 31.32M |
| 297 | ALEC | Alector, Inc. | 209.57M | 4.92% | 691,490 | 69.05M |
| 298 | EDIT | Editas Medicine, Inc. | 206.95M | 4.95% | 1,992,506 | 46.38M |
| 299 | ARCT | Arcturus Therapeutics Holdings Inc. | 206.57M | 2.39% | 357,814 | 97.60M |
| 300 | SGMT | Sagimet Biosciences Inc. | 206.51M | 1.11% | 242,823 | - |
| 301 | CCCC | C4 Therapeutics, Inc. | 205.46M | -2.75% | 1,138,909 | 30.11M |
| 302 | CLYM | Climb Bio, Inc. | 204.82M | -0.69% | 427,349 | - |
| 303 | GALT | Galectin Therapeutics Inc. | 204.38M | 6.02% | 448,452 | - |
| 304 | MIST | Milestone Pharmaceuticals Inc. | 204.18M | - | 2,511,147 | - |
| 305 | RNAC | Cartesian Therapeutics, Inc. | 198.67M | 5.67% | 107,175 | 1.09M |
| 306 | CHRS | Coherus Oncology, Inc. | 198.23M | 5.81% | 843,111 | 277.73M |
| 307 | CGEN | Compugen Ltd. | 197.36M | -3.21% | 441,973 | 6.90M |
| 308 | CRDF | Cardiff Oncology, Inc. | 194.67M | 2.85% | 348,346 | 501.00K |
| 309 | SABS | SAB Biotherapeutics, Inc. | 191.86M | 0.50% | 574,885 | 114.70K |
| 310 | ZNTL | Zentalis Pharmaceuticals, Inc. | 191.01M | 2.79% | 814,599 | 26.87M |
| 311 | HUMA | Humacyte, Inc. | 189.14M | -3.92% | 8,941,049 | 1.57M |
| 312 | KLRS | Kalaris Therapeutics, Inc. | 183.10M | -0.20% | 29,542 | - |
| 313 | NERV | Minerva Neurosciences, Inc. | 181.32M | -4.12% | 67,014 | - |
| 314 | QNCX | Quince Therapeutics, Inc. | 180.96M | -4.97% | 940,727 | - |
| 315 | IPSC | Century Therapeutics, Inc. | 178.12M | 6.25% | 1,613,330 | 113.34M |
| 316 | SLGL | Sol-Gel Technologies Ltd. | 175.53M | -12.61% | 28,545 | 18.97M |
| 317 | ELDN | Eledon Pharmaceuticals, Inc. | 174.58M | -0.45% | 706,089 | - |
| 318 | PRQR | ProQR Therapeutics N.V. | 172.77M | -2.38% | 401,146 | 18.86M |
| 319 | PLX | Protalix BioTherapeutics, Inc. | 166.47M | 0.98% | 907,659 | 61.84M |
| 320 | SRZN | Surrozen, Inc. | 164.31M | 6.62% | 58,460 | 3.60M |
| 321 | RANI | Rani Therapeutics Holdings, Inc. | 164.05M | -0.74% | 1,076,057 | 1.20M |
| 322 | IRD | Opus Genetics, Inc. | 162.76M | 4.42% | 1,613,647 | 14.63M |
| 323 | IPHA | Innate Pharma S.A. | 162.41M | - | 6,357 | 14.84M |
| 324 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 160.46M | 0.81% | 133,438 | - |
| 325 | VXRT | Vaxart, Inc. | 159.42M | -3.48% | - | 148.20M |
| 326 | NTHI | NeOnc Technologies Holdings, Inc. | 156.96M | -3.59% | 35,004 | 59.99K |
| 327 | NKTX | Nkarta, Inc. | 156.26M | 7.84% | 1,036,993 | - |
| 328 | TNYA | Tenaya Therapeutics, Inc. | 155.00M | 1.95% | 2,123,882 | - |
| 329 | CDXS | Codexis, Inc. | 154.45M | 6.21% | 414,960 | 52.93M |
| 330 | CNTX | Context Therapeutics Inc. | 150.68M | 6.49% | 2,178,568 | - |
| 331 | PRLD | Prelude Therapeutics Incorporated | 149.96M | -1.09% | 237,899 | 10.50M |
| 332 | MOLN | Molecular Partners AG | 147.25M | -0.15% | 3,705 | 856.30K |
| 333 | BDTX | Black Diamond Therapeutics, Inc. | 146.43M | 7.08% | 1,148,560 | 70.00M |
| 334 | UNCY | Unicycive Therapeutics, Inc. | 141.84M | 0.30% | 425,789 | - |
| 335 | CNTB | Connect Biopharma Holdings Limited | 139.76M | 8.70% | 83,396 | 762.00K |
| 336 | CRBU | Caribou Biosciences, Inc. | 139.27M | 7.19% | 1,394,718 | 9.30M |
| 337 | ELTX | Elicio Therapeutics, Inc. | 138.05M | -0.63% | 60,396 | - |
| 338 | ORMP | Oramed Pharmaceuticals Inc. | 136.92M | -2.27% | 237,625 | 2.00M |
| 339 | TTRX | Turn Therapeutics Inc. | 136.63M | 0.43% | 37,059 | - |
| 340 | ACTU | Actuate Therapeutics, Inc. | 136.32M | 5.49% | 39,772 | - |
| 341 | MCRB | Seres Therapeutics, Inc. | 136.15M | -0.07% | 34,499 | 351.00K |
| 342 | FATE | Fate Therapeutics, Inc. | 136.12M | 7.27% | 1,473,647 | 7.14M |
| 343 | STRO | Sutro Biopharma, Inc. | 134.61M | 5.90% | 274,327 | 105.65M |
| 344 | SPRO | Spero Therapeutics, Inc. | 132.96M | -0.84% | 160,214 | 40.55M |
| 345 | WHWK | Whitehawk Therapeutics, Inc. | 131.96M | -2.10% | 63,643 | 14.38M |
| 346 | SGMO | Sangamo Therapeutics, Inc. | 127.97M | 3.91% | 4,193,146 | 32.88M |
| 347 | ACOG | Alpha Cognition Inc. | 127.19M | 4.84% | 168,291 | 7.43M |
| 348 | ONCY | Oncolytics Biotech Inc. | 125.90M | 18.11% | 4,001,569 | - |
| 349 | CGTX | Cognition Therapeutics, Inc. | 125.35M | 1.43% | 600,249 | - |
| 350 | GNLX | Genelux Corporation | 125.33M | 3.66% | 207,305 | 8.00K |
| 351 | VRCA | Verrica Pharmaceuticals Inc. | 124.08M | -2.27% | 105,005 | 30.83M |
| 352 | ARTV | Artiva Biotherapeutics, Inc. | 116.59M | 2.81% | 323,988 | 251.00K |
| 353 | KPTI | Karyopharm Therapeutics Inc. | 115.72M | 6.22% | 481,279 | 142.53M |
| 354 | AGEN | Agenus Inc. | 115.63M | 0.89% | 889,045 | 106.83M |
| 355 | RPTX | Repare Therapeutics Inc. | 111.65M | 0.39% | 937,440 | 11.87M |
| 356 | MGNX | MacroGenics, Inc. | 110.39M | -0.29% | 392,899 | 127.63M |
| 357 | THAR | Tharimmune, Inc. | 110.29M | -4.45% | 475,587 | - |
| 358 | VANI | Vivani Medical, Inc. | 110.16M | 11.03% | 1,692,562 | - |
| 359 | ABOS | Acumen Pharmaceuticals, Inc. | 109.64M | -2.69% | 212,438 | - |
| 360 | FBIO | Fortress Biotech, Inc. | 107.39M | -0.57% | 542,306 | 62.30M |
| 361 | SEER | Seer, Inc. | 105.75M | 1.08% | 91,254 | 16.38M |
| 362 | ANIX | Anixa Biosciences, Inc. | 105.63M | 1.77% | 129,437 | - |
| 363 | SAVA | Cassava Sciences, Inc. | 104.83M | 9.05% | 1,546,361 | - |
| 364 | INO | Inovio Pharmaceuticals, Inc. | 103.74M | - | 750,502 | 182.34K |
| 365 | PYXS | Pyxis Oncology, Inc. | 103.36M | - | 531,759 | 2.82M |
| 366 | BMEA | Biomea Fusion, Inc. | 99.69M | 2.17% | 909,253 | - |
| 367 | EXOZ | eXoZymes, Inc. | 98.96M | 6.51% | 7,389 | -700.00 |
| 368 | CSBR | Champions Oncology, Inc. | 98.45M | 1.29% | 1,863 | 58.42M |
| 369 | DTIL | Precision BioSciences, Inc. | 96.53M | -3.84% | 202,655 | 698.00K |
| 370 | ETHZ | ETHZilla Corporation | 96.20M | -0.39% | 529,278 | 4.11M |
| 371 | COYA | Coya Therapeutics, Inc. | 95.21M | 1.56% | 302,284 | 3.99M |
| 372 | HYFT | MindWalk Holdings Corp. | 94.78M | 4.10% | 392,817 | 19.02M |
| 373 | DWTX | Dogwood Therapeutics, Inc. | 91.44M | 4.01% | 26,102 | - |
| 374 | MAIA | MAIA Biotechnology, Inc. | 89.54M | 6.36% | 1,366,123 | - |
| 375 | KRRO | Korro Bio, Inc. | 89.18M | 10.37% | 210,742 | 7.37M |
| 376 | SPRB | Spruce Biosciences, Inc. | 84.47M | 10.44% | 36,544 | 697.00K |
| 377 | MREO | Mereo BioPharma Group plc | 84.34M | -6.21% | 12,527,438 | 500.00K |
| 378 | MNOV | MediciNova, Inc. | 82.57M | - | 83,524 | 257.92K |
| 379 | CBUS | Cibus, Inc. | 81.88M | -11.44% | 423,046 | 3.79M |
| 380 | ACET | Adicet Bio, Inc. | 81.56M | 2.15% | 248,267 | - |
| 381 | CALC | CalciMedica, Inc. | 80.26M | -0.54% | 37,095 | - |
| 382 | ALXO | ALX Oncology Holdings Inc. | 79.70M | 11.36% | 254,179 | - |
| 383 | ADAG | Adagene Inc. | 79.65M | -9.63% | 34,716 | 103.20K |
| 384 | IMUX | Immunic, Inc. | 79.30M | 2.26% | 1,196,845 | - |
| 385 | OKYO | OKYO Pharma Limited | 78.23M | -3.26% | 300,931 | - |
| 386 | ATOS | Atossa Therapeutics, Inc. | 77.93M | 0.05% | 914,402 | - |
| 387 | XBIT | XBiotech Inc. | 77.74M | 0.79% | 35,908 | - |
| 388 | PLRX | Pliant Therapeutics, Inc. | 77.43M | -1.56% | 1,102,846 | - |
| 389 | KZIA | Kazia Therapeutics Limited | 77.15M | 0.57% | 136,260 | 1.20M |
| 390 | PYPD | PolyPid Ltd. | 76.35M | 2.91% | 141,526 | - |
| 391 | ANVS | Annovis Bio, Inc. | 76.33M | 3.23% | 419,810 | - |
| 392 | GANX | Gain Therapeutics, Inc. | 75.77M | -1.01% | 957,062 | - |
| 393 | IMA | ImageneBio, Inc. | 75.62M | 12.70% | 56,612 | 800.00K |
| 394 | COEP | Coeptis Therapeutics Holdings, Inc. | 75.49M | 7.44% | 28,368 | 501.00K |
| 395 | ENTX | Entera Bio Ltd. | 72.45M | 0.64% | 169,093 | 124.00K |
| 396 | PTHS | Pelthos Therapeutics Inc. | 71.09M | 3.04% | 7,995 | 7.41M |
| 397 | ATYR | aTyr Pharma, Inc. | 69.51M | 0.41% | 828,021 | 190.00K |
| 398 | BYSI | BeyondSpring Inc. | 68.67M | -1.76% | 25,875 | 1.88M |
| 399 | ANL | Adlai Nortye Ltd. | 68.27M | - | 41,438 | -1.35M |
| 400 | IFRX | InflaRx N.V. | 67.75M | 1.11% | 320,923 | 73.73K |
| 401 | EQ | Equillium, Inc. | 67.59M | -3.48% | 165,475 | 4.39M |
| 402 | TVGN | Tevogen Bio Holdings Inc. | 67.27M | 4.97% | 152,659 | - |
| 403 | NRXP | NRx Pharmaceuticals, Inc. | 66.91M | 3.67% | 395,431 | 242.00K |
| 404 | ACRV | Acrivon Therapeutics, Inc. | 65.95M | 6.63% | 957,662 | - |
| 405 | TCRX | TScan Therapeutics, Inc. | 64.69M | 1.79% | 331,934 | 8.42M |
| 406 | ICCC | ImmuCell Corporation | 61.51M | 4.29% | 11,406 | 27.77M |
| 407 | CRVO | CervoMed Inc. | 61.44M | -5.01% | 132,254 | 6.16M |
| 408 | MGX | Metagenomi Therapeutics, Inc. | 61.20M | 1.24% | 247,096 | 30.91M |
| 409 | ATHE | Alterity Therapeutics Limited | 58.84M | -1.52% | 15,021 | 3.57M |
| 410 | INKT | MiNK Therapeutics, Inc. | 57.64M | 3.89% | 7,782 | - |
| 411 | RADX | Radiopharm Theranostics Limited | 57.52M | -2.59% | 45,137 | 8.20M |
| 412 | GRCE | Grace Therapeutics, Inc. | 56.79M | 2.80% | 72,806 | - |
| 413 | PMVP | PMV Pharmaceuticals, Inc. | 56.40M | -1.85% | 683,853 | - |
| 414 | NTRB | Nutriband Inc. | 55.13M | -1.41% | 19,954 | 2.28M |
| 415 | LPCN | Lipocine Inc. | 53.80M | -2.32% | 124,881 | 4.32M |
| 416 | OSTX | OS Therapies Incorporated | 52.82M | - | 423,882 | - |
| 417 | IBO | Impact BioMedical Inc. | 52.31M | 8.98% | 72,714 | 25.00K |
| 418 | NRXS | NeurAxis, Inc. | 52.31M | 5.59% | 197,678 | 3.36M |
| 419 | PSTV | Plus Therapeutics, Inc. | 51.62M | 2.31% | 12,970,439 | 5.26M |
| 420 | QTTB | Q32 Bio Inc. | 51.43M | 6.36% | 204,234 | - |
| 421 | PDSB | PDS Biotechnology Corporation | 50.97M | -1.53% | 790,265 | - |
| 422 | IBIO | iBio, Inc. | 50.37M | - | 1,240,997 | 500.00K |
| 423 | ALGS | Aligos Therapeutics, Inc. | 49.23M | -0.12% | 80,965 | 2.65M |
| 424 | ABVC | ABVC BioPharma, Inc. | 48.56M | -4.19% | 76,456 | 797.92K |
| 425 | LITS | Lite Strategy, Inc. | 48.54M | 0.76% | 900,137 | - |
| 426 | TIL | Instil Bio, Inc. | 48.02M | - | 83,699 | - |
| 427 | NXTC | NextCure, Inc. | 45.54M | -2.03% | 5,523 | - |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 45.38M | -0.75% | 98,099 | - |
| 429 | KZR | Kezar Life Sciences, Inc. | 45.33M | 0.65% | 24,638 | - |
| 430 | GLTO | Galecto, Inc. | 45.00M | 0.86% | 32,236 | - |
| 431 | ANEB | Anebulo Pharmaceuticals, Inc. | 44.78M | 1.83% | 72,619 | - |
| 432 | CVM | CEL-SCI Corporation | 44.23M | 0.19% | 34,451 | - |
| 433 | TVRD | Tvardi Therapeutics, Inc. | 44.09M | 1.51% | 50,864 | - |
| 434 | INMB | INmune Bio Inc. | 43.60M | 2.50% | 309,939 | 50.00K |
| 435 | JSPR | Jasper Therapeutics, Inc. | 42.54M | -1.30% | 471,806 | - |
| 436 | HURA | TuHURA Biosciences, Inc. | 41.71M | 0.90% | 280,669 | - |
| 437 | VERU | Veru Inc. | 41.57M | 1.57% | 163,279 | 16.89M |
| 438 | APLM | Apollomics, Inc. | 41.56M | -3.80% | 30,148 | 6.93M |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 41.18M | 3.13% | 172,198 | 90.00K |
| 440 | XLO | Xilio Therapeutics, Inc. | 40.33M | -4.62% | 600,053 | 31.80M |
| 441 | XCUR | Exicure, Inc. | 40.03M | 2.28% | 39,087 | 500.00K |
| 442 | CING | Cingulate Inc. | 39.73M | -6.27% | 346,986 | - |
| 443 | PASG | Passage Bio, Inc. | 39.16M | -3.52% | 88,951 | - |
| 444 | OKUR | OnKure Therapeutics, Inc. | 38.75M | -3.87% | 50,852 | - |
| 445 | ESLA | Estrella Immunopharma, Inc. | 38.37M | 0.21% | 43,104 | - |
| 446 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 38.21M | -3.20% | 3,132,187 | - |
| 447 | LTRN | Lantern Pharma Inc. | 37.92M | -5.57% | 59,857 | - |
| 448 | GBIO | Generation Bio Co. | 36.85M | -2.33% | 233,026 | 15.27M |
| 449 | RNXT | RenovoRx, Inc. | 36.56M | -4.08% | 190,025 | 928.00K |
| 450 | MRKR | Marker Therapeutics, Inc. | 36.51M | 3.30% | 769,209 | 4.69M |
| 451 | CELU | Celularity Inc. | 36.34M | -4.55% | 6,552 | 40.58M |
| 452 | KYNB | Kyntra Bio, Inc. | 35.84M | 3.63% | 20,216 | 8.30M |
| 453 | LSTA | Lisata Therapeutics, Inc. | 35.55M | 86.57% | 4,959,964 | 1.07M |
| 454 | EVAX | Evaxion A/S | 34.86M | -10.68% | 139,039 | 7.65M |
| 455 | CUE | Cue Biopharma, Inc. | 34.28M | 25.69% | 6,747,472 | 7.10M |
| 456 | ATRA | Atara Biotherapeutics, Inc. | 33.17M | 6.48% | 418,199 | 151.93M |
| 457 | OTLK | Outlook Therapeutics, Inc. | 32.44M | -2.69% | 2,603,383 | 1.41M |
| 458 | ANTX | AN2 Therapeutics, Inc. | 32.33M | - | 86,503 | - |
| 459 | DYAI | Dyadic International, Inc. | 32.14M | 0.30% | 13,190 | 3.34M |
| 460 | JUNS | Jupiter Neurosciences, Inc. | 32.00M | 3.28% | 27,951 | - |
| 461 | RNTX | Rein Therapeutics Inc. | 31.81M | 0.83% | 146,627 | - |
| 462 | SKYE | Skye Bioscience, Inc. | 31.44M | 0.79% | 134,188 | - |
| 463 | GNTA | Genenta Science S.p.A. | 30.93M | -2.22% | 31,533 | - |
| 464 | SER | Serina Therapeutics, Inc. | 30.39M | -0.70% | 32,786 | 116.00K |
| 465 | PLUR | Pluri Inc. | 30.03M | -2.27% | 6,229 | 1.33M |
| 466 | PTN | Palatin Technologies, Inc. | 29.89M | -2.97% | 27,504 | 8.85M |
| 467 | HOWL | Werewolf Therapeutics, Inc. | 29.03M | 5.95% | 390,168 | 1.14M |
| 468 | BRNS | Barinthus Biotherapeutics plc | 28.99M | -1.39% | 50,541 | 14.97M |
| 469 | RLYB | Rallybio Corporation | 28.89M | 11.22% | 308,745 | 674.00K |
| 470 | NRSN | NeuroSense Therapeutics Ltd. | 28.72M | -5.19% | 1,367,306 | - |
| 471 | SNTI | Senti Biosciences, Inc. | 28.39M | 0.93% | 244,226 | - |
| 472 | BOLD | Boundless Bio, Inc. | 27.76M | 0.81% | 170,556 | - |
| 473 | DARE | Daré Bioscience, Inc. | 27.72M | -1.02% | 100,521 | -57.13K |
| 474 | LIXT | Lixte Biotechnology Holdings, Inc. | 27.53M | 3.95% | 133,437 | - |
| 475 | IGC | IGC Pharma, Inc. | 26.89M | 0.18% | 400,986 | 1.11M |
| 476 | PLRZ | Polyrizon Ltd. | 25.49M | 9.60% | 154,025 | - |
| 477 | NNVC | NanoViricides, Inc. | 25.45M | 4.42% | 265,400 | - |
| 478 | VTGN | Vistagen Therapeutics, Inc. | 25.05M | -1.70% | 918,867 | 721.00K |
| 479 | QNTM | Quantum BioPharma Ltd. | 24.99M | -11.08% | 67,541 | - |
| 480 | LONA | LeonaBio, Inc. | 24.69M | 0.81% | 33,560 | - |
| 481 | KLTO | Klotho Neurosciences, Inc. | 24.27M | 6.11% | 590,561 | - |
| 482 | INTS | Intensity Therapeutics, Inc. | 23.85M | -0.58% | 1,554,469 | - |
| 483 | HYPD | Hyperion DeFi, Inc. | 23.77M | -1.39% | 194,475 | 345.32K |
| 484 | INAB | IN8bio, Inc. | 22.76M | -1.27% | 59,469 | - |
| 485 | NEUP | Neuphoria Therapeutics Inc. | 21.72M | 0.25% | 50,102 | 15.65M |
| 486 | FBLG | FibroBiologics, Inc. | 21.72M | 1.24% | 249,687 | - |
| 487 | KTTA | Pasithea Therapeutics Corp. | 21.01M | -1.89% | 131,409 | - |
| 488 | CASI | CASI Pharmaceuticals, Inc. | 20.55M | 1.01% | 17,759 | 26.85M |
| 489 | ALLR | Allarity Therapeutics, Inc. | 20.49M | 1.72% | 76,881 | - |
| 490 | LEXX | Lexaria Bioscience Corp. | 19.91M | 8.74% | 131,339 | 522.00K |
| 491 | LNAI | Lunai Bioworks Inc. | 19.68M | -3.00% | 102,291 | - |
| 492 | TRAW | Traws Pharma, Inc. | 19.42M | -5.81% | 238,784 | 2.85M |
| 493 | LIMN | Liminatus Pharma, Inc. | 19.36M | -1.99% | 50,444 | - |
| 494 | VYNE | VYNE Therapeutics Inc. | 19.30M | 1.01% | 406,097 | 524.00K |
| 495 | BCAB | BioAtla, Inc. | 19.04M | -6.43% | 2,088,302 | 11.00M |
| 496 | CLGN | CollPlant Biotechnologies Ltd. | 18.01M | -4.08% | 15,910 | 2.48M |
| 497 | OSRH | OSR Holdings, Inc. | 17.84M | -3.31% | 1,266,526 | -90.52K |
| 498 | PMN | ProMIS Neurosciences, Inc. | 17.76M | 1.12% | 5,659 | - |
| 499 | KAPA | Kairos Pharma, Ltd. | 17.70M | -2.83% | 119,343 | - |
| 500 | KALA | KALA BIO, Inc. | 17.02M | - | 695,229 | - |
| 501 | ITRM | Iterum Therapeutics plc | 16.75M | -3.76% | 334,829 | 390.00K |
| 502 | CVKD | Cadrenal Therapeutics, Inc. | 16.62M | -3.53% | 43,299 | - |
| 503 | CTXR | Citius Pharmaceuticals, Inc. | 16.61M | -1.34% | 287,239 | - |
| 504 | HOTH | Hoth Therapeutics, Inc. | 16.29M | -1.87% | 4,570,044 | - |
| 505 | AEON | AEON Biopharma, Inc. | 16.10M | 13.33% | 492,540 | - |
| 506 | CLRB | Cellectar Biosciences, Inc. | 15.48M | 4.29% | 39,257 | - |
| 507 | APLT | Applied Therapeutics, Inc. | 15.46M | 1.40% | 5,253,275 | 1.00M |
| 508 | IOBT | IO Biotech, Inc. | 14.94M | -59.74% | 36,576,902 | - |
| 509 | MBRX | Moleculin Biotech, Inc. | 14.66M | 11.74% | 223,714 | - |
| 510 | COCP | Cocrystal Pharma, Inc. | 14.34M | -0.95% | 66,617 | - |
| 511 | SNGX | Soligenix, Inc. | 14.12M | 1.45% | 235,619 | 2.34K |
| 512 | BCDA | BioCardia, Inc. | 13.58M | -1.54% | 81,999 | 3.00K |
| 513 | NCNA | NuCana plc | 13.53M | 1.25% | 57,852 | - |
| 514 | TPST | Tempest Therapeutics, Inc. | 12.86M | 1.16% | 21,177 | - |
| 515 | BLRX | BioLineRx Ltd. | 12.42M | 0.71% | 8,292 | 12.74M |
| 516 | GDTC | CytoMed Therapeutics Limited | 12.22M | 0.85% | 11,763 | 573.19K |
| 517 | BOLT | Bolt Biotherapeutics, Inc. | 12.03M | 0.48% | 16,903 | 5.20M |
| 518 | EDSA | Edesa Biotech, Inc. | 12.00M | -1.37% | 73,919 | - |
| 519 | AKTX | Akari Therapeutics, Plc | 11.94M | -1.14% | 247,985 | - |
| 520 | SNSE | Sensei Biotherapeutics, Inc. | 11.87M | -2.08% | 17,673 | - |
| 521 | IMNN | Imunon, Inc. | 11.83M | 0.58% | 24,550 | - |
| 522 | CRIS | Curis, Inc. | 11.57M | -7.54% | 332,239 | 11.65M |
| 523 | LGVN | Longeveron Inc. | 11.37M | 0.38% | 64,691 | 1.44M |
| 524 | GRDX | GridAI Technologies Corp. | 11.23M | 1.83% | 115,128 | - |
| 525 | PHIO | Phio Pharmaceuticals Corp. | 11.20M | -3.70% | 383,136 | - |
| 526 | NCEL | NewcelX Ltd. | 11.03M | -2.42% | 49,450 | - |
| 527 | CMMB | Chemomab Therapeutics Ltd. | 10.59M | 8.86% | 58,648 | - |
| 528 | BRTX | BioRestorative Therapies, Inc. | 10.39M | 4.46% | 6,793 | 383.40K |
| 529 | PULM | Pulmatrix, Inc. | 9.61M | -1.50% | 29,839 | 3.00K |
| 530 | APVO | Aptevo Therapeutics Inc. | 9.27M | -5.49% | 94,989 | - |
| 531 | ERNA | Ernexa Therapeutics Inc. | 9.26M | -3.28% | 102,501 | 1,000.00 |
| 532 | MTVA | MetaVia Inc. | 9.24M | -4.00% | 460,410 | - |
| 533 | ALZN | Alzamend Neuro, Inc. | 9.24M | 0.41% | 80,755 | - |
| 534 | BIVI | BioVie Inc. | 9.04M | -1.64% | 92,188 | - |
| 535 | ABP | Abpro Holdings, Inc. | 8.88M | 5.83% | 13,476 | 183.00K |
| 536 | PMCB | PharmaCyte Biotech, Inc. | 8.87M | 2.29% | 143,789 | - |
| 537 | EVGN | Evogene Ltd. | 8.70M | 0.99% | 16,987 | 8.02M |
| 538 | RNAZ | TransCode Therapeutics, Inc. | 8.60M | 7.32% | 9,748 | - |
| 539 | IMRN | Immuron Limited | 8.56M | 0.61% | 27,876 | 4.78M |
| 540 | XTLB | XTL Biopharmaceuticals Ltd. | 8.40M | 0.33% | 134,122 | 968.00K |
| 541 | QNRX | Quoin Pharmaceuticals, Ltd. | 8.36M | -4.59% | 39,394 | - |
| 542 | ICU | SeaStar Medical Holding Corporation | 8.18M | -0.44% | 66,238 | 881.00K |
| 543 | KPRX | Kiora Pharmaceuticals, Inc. | 8.00M | -1.36% | 9,410 | 20.00K |
| 544 | APM | Aptorum Group Limited | 7.98M | -3.92% | 38,663 | - |
| 545 | BCTX | BriaCell Therapeutics Corp. | 7.95M | -3.66% | 399,936 | - |
| 546 | ADXN | Addex Therapeutics Ltd | 7.93M | 0.85% | 2,951 | 198.82K |
| 547 | GTBP | GT Biopharma, Inc. | 7.55M | -2.11% | 872,161 | - |
| 548 | CLDI | Calidi Biotherapeutics, Inc. | 7.32M | -0.99% | 51,632 | - |
| 549 | MBIO | Mustang Bio, Inc. | 7.30M | -2.91% | 55,071 | - |
| 550 | PCSA | Processa Pharmaceuticals, Inc. | 7.09M | -3.40% | 45,922 | - |
| 551 | BGMS | Bio Green Med Solution, Inc. | 6.86M | -4.31% | 23,639 | 81.00K |
| 552 | TOVX | Theriva Biologics, Inc. | 6.84M | 6.02% | 1,678,433 | - |
| 553 | CELZ | Creative Medical Technology Holdings, Inc. | 6.81M | -1.52% | 140,917 | 6.00K |
| 554 | TCRT | Alaunos Therapeutics, Inc. | 6.70M | 3.09% | 16,980 | 6.00K |
| 555 | SLXN | Silexion Therapeutics Corp | 6.60M | -5.80% | 42,466 | - |
| 556 | GNPX | Genprex, Inc. | 6.56M | 0.35% | 762,925 | - |
| 557 | PPBT | Purple Biotech Ltd | 6.48M | 0.30% | 87,894 | - |
| 558 | ADIL | Adial Pharmaceuticals, Inc. | 6.04M | 0.51% | 198,891 | - |
| 559 | ACXP | Acurx Pharmaceuticals, Inc. | 5.96M | -0.39% | 37,888 | - |
| 560 | APRE | Aprea Therapeutics, Inc. | 5.82M | -4.98% | 97,946 | 488.24K |
| 561 | INDP | Indaptus Therapeutics, Inc. | 5.74M | -8.30% | 103,764 | - |
| 562 | XBIO | Xenetic Biosciences, Inc. | 5.54M | -3.20% | 28,004 | 2.86M |
| 563 | CANF | Can-Fite BioPharma Ltd. | 5.37M | 2.26% | 59,096 | 560.00K |
| 564 | VIVS | VivoSim Labs, Inc. | 5.17M | -3.74% | 17,250 | 140.00K |
| 565 | CYCN | Cyclerion Therapeutics, Inc. | 5.14M | - | 59,859 | 2.86M |
| 566 | ASBP | Aspire Biopharma Holdings, Inc. | 5.13M | -4.98% | 299,698 | 1.94K |
| 567 | GOVX | GeoVax Labs, Inc. | 5.12M | 6.81% | 146,591 | 3.35M |
| 568 | REVB | Revelation Biosciences, Inc. | 4.98M | -10.08% | 5,481,365 | - |
| 569 | SILO | Silo Pharma, Inc. | 4.74M | -1.47% | 47,379 | 72.10K |
| 570 | PHGE | BiomX Inc. | 4.67M | 11.27% | 61,492 | - |
| 571 | SPRC | SciSparc Ltd. | 4.57M | -4.55% | 3,117,734 | 1.31M |
| 572 | DCOY | Decoy Therapeutics Inc. | 4.55M | -12.55% | 459,931 | - |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 4.46M | 1.72% | 22,683 | - |
| 574 | ENVB | Enveric Biosciences, Inc. | 4.27M | 3.22% | 39,437 | - |
| 575 | CNSP | CNS Pharmaceuticals, Inc. | 4.17M | -7.57% | 44,009 | - |
| 576 | OGEN | Oragenics, Inc. | 4.13M | 2.06% | 145,667 | - |
| 577 | XRTX | XORTX Therapeutics Inc. | 4.02M | 2.12% | 16,168 | - |
| 578 | ELAB | PMGC Holdings Inc. | 4.01M | 4.32% | 140,243 | 285.95K |
| 579 | LYRA | Lyra Therapeutics, Inc. | 3.99M | -3.85% | 60,623 | 600.00K |
| 580 | CMND | Clearmind Medicine Inc. | 3.84M | -3.03% | 35,774 | - |
| 581 | MTNB | Matinas BioPharma Holdings, Inc. | 3.78M | -7.44% | 69,513 | - |
| 582 | JAGX | Jaguar Health, Inc. | 3.67M | -5.37% | 2,182,468 | 11.79M |
| 583 | PPCB | Propanc Biopharma, Inc. | 3.62M | -9.37% | 537,895 | - |
| 584 | HCWB | HCW Biologics Inc. | 3.59M | -1.48% | 59,434 | 422.03K |
| 585 | ARTL | Artelo Biosciences, Inc. | 3.45M | 3.01% | 56,234 | - |
| 586 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.36M | 5.14% | 126,335 | 15.78K |
| 587 | ENSC | Ensysce Biosciences, Inc. | 3.33M | -2.23% | 136,961 | 4.49M |
| 588 | GRI | GRI Bio, Inc. | 3.11M | -4.21% | 2,514,607 | - |
| 589 | BBLG | Bone Biologics Corporation | 3.09M | -0.58% | 30,579 | - |
| 590 | AZTR | Azitra, Inc. | 3.07M | -4.41% | 883,732 | 7.50K |
| 591 | SCNI | Scinai Immunotherapeutics Ltd. | 2.94M | -2.00% | 8,529 | 1.15M |
| 592 | ADTX | Aditxt, Inc. | 2.59M | 23.73% | 25,399,754 | 5.95K |
| 593 | CDT | CDT Equity Inc. | 2.50M | -2.04% | 150,786 | - |
| 594 | ONCO | Onconetix, Inc. | 2.49M | -8.57% | 33,891 | 1.22M |
| 595 | DRMA | Dermata Therapeutics, Inc. | 2.45M | -4.15% | 178,257 | - |
| 596 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.12M | -0.50% | 529,360 | 1.36M |
| 597 | VRAX | Virax Biolabs Group Limited | 2.03M | -4.55% | 495,298 | 2.99K |
| 598 | BDRX | Biodexa Pharmaceuticals Plc | 1.76M | -4.98% | 147,081 | 104.90K |
| 599 | MLEC | Moolec Science SA | 1.73M | 47.61% | 5,675,309 | 7.83M |
| 600 | PBM | Psyence Biomedical Ltd. | 890.11K | - | 2,469,411 | - |